Listen to the article
Growing concerns have emerged about the misuse of ivermectin for cancer treatment, coinciding with legislative efforts to expand access to the controversial drug across multiple states.
Despite lacking FDA approval for cancer treatment, ivermectin has gained traction on social media as a purported cancer therapy. KFF monitoring reveals that cancer-related posts mentioning ivermectin doubled in the first half of 2025 compared to all of 2024, now accounting for over 4% of cancer-related content in their searches.
The medication, primarily approved for treating specific parasitic infections like strongyloidiasis and onchocerciasis, has been championed by influencers with substantial followings. One medical influencer with over 565,000 followers on X recently promoted ivermectin as a “cutting-edge” cancer treatment, sharing anecdotal success stories without scientific validation.
This social media trend parallels policy developments at the state level. Sixteen states have introduced or passed legislation to make ivermectin available over-the-counter, despite pharmacists expressing reluctance to dispense it without FDA approval for such uses.
Health officials warn that ivermectin can interact dangerously with other medications, particularly blood thinners, and overdoses may lead to seizures, coma, or death. Perhaps more concerning is that patients pursuing ivermectin might delay seeking proven cancer therapies, potentially increasing mortality rates.
The ivermectin controversy follows a pattern of misinformation surrounding COVID-19. KFF polling from 2023 found that about half of Americans had heard the false claim that ivermectin effectively treats COVID-19. While only 6% believed this claim was definitely true, 70% expressed uncertainty about its validity. Political affiliations showed a stark divide, with 48% of Republicans believing or leaning toward believing the false claim, compared to just 18% of Democrats.
Meanwhile, unsubstantiated “detox” products targeting supposed spike protein from COVID-19 vaccines have gained renewed attention online. These products, often priced at around $90, claim to “break down spike protein and disrupt its function” despite scientific evidence showing the spike protein from vaccines typically clears from the body within days.
One popular “detox” formula, promoted by a doctor whose credentials were revoked for spreading COVID-19 vaccine misinformation, contains nattokinase, bromelain, and curcumin. While generally considered safe as supplements, these ingredients can thin blood and potentially cause harmful interactions with medications.
In the reproductive health arena, an equally concerning trend has emerged. Anti-abortion advocates have begun circulating baseless claims that medication abortion pills contaminate water supplies. Despite federal agencies and researchers finding no evidence that mifepristone appears in water at harmful levels, the narrative gained traction when a group opposing abortion access claimed that over 40 tons of fetal remains and abortion pill byproducts have entered the water system.
This unsubstantiated claim prompted 25 Republican legislators to demand an EPA investigation, despite an FDA environmental assessment estimating mifepristone’s environmental concentration at less than one part per billion—too low to affect test organisms. Nevertheless, lawmakers in Wyoming and Texas have introduced bills requiring testing of water supplies for abortion medication byproduct.
The mental health field faces similar challenges with renewed debates over ADHD medications. A resurfaced 2005 interview with actor Tom Cruise criticizing psychiatric diagnoses became the most shared ADHD-related post on X between late May and June 2025. The video reignited claims about pharmaceutical companies’ influence on mental health care, despite studies showing ADHD medications reduce risks of criminality, self-harm, and other negative outcomes.
These narratives coincide with the White House’s Make America Healthy Again Commission identifying ADHD “overmedicalization” as contributing to childhood chronic disease—claims disputed by specialists and advocacy groups who argue the cited research is flawed.
As healthcare increasingly intersects with technology, a Massachusetts Institute of Technology study found that artificial intelligence tools may provide inconsistent medical advice based on minor text variations. The research revealed that large language models were 7-9% more likely to recommend self-management rather than seeking medical care when messages contained typos or colloquial language, with women receiving about 7% more errors in recommendations.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
18 Comments
While I understand the desire for alternative cancer therapies, promoting ivermectin without scientific validation is irresponsible and could put patients at risk. Policymakers should focus on expanding access to proven, safe treatments, not unproven remedies.
Well said. Ivermectin may have a legitimate role in treating certain parasitic infections, but using it for cancer is simply not supported by the evidence.
The trend of using ivermectin for unapproved purposes like cancer treatment is alarming. Doctors and regulators need to strongly discourage this, as it could distract from legitimate cancer care and lead to dangerous side effects.
Absolutely. Spreading unfounded claims about ivermectin on social media is irresponsible and could have serious public health consequences.
The rise of ivermectin misinformation around cancer treatment is extremely concerning. We need robust public health campaigns to counter these dangerous myths and ensure patients have access to legitimate, evidence-based care.
I agree completely. Relying on social media influencers rather than medical experts when it comes to cancer treatment is a recipe for disaster.
The growing push to expand ivermectin access for cancer treatment is deeply concerning. This undermines public trust in legitimate medical authorities and could lead patients to forgo proven therapies in favor of unproven, potentially dangerous alternatives.
I agree. Responsible policymaking requires following the science, not catering to misinformation campaigns, no matter how persistent they may be.
The growing traction of ivermectin as a purported cancer treatment is very concerning. We need to counter this misinformation campaign with facts and evidence-based medicine, not enable the spread of dangerous myths.
I agree. Responsible journalism and public health messaging are crucial to ensure patients get accurate information and safe, effective care.
While the desire for alternative cancer treatments is understandable, the promotion of ivermectin as a ‘cutting-edge’ therapy is simply not supported by the scientific evidence. We need to be very cautious about expanding access to unproven remedies, as the risks could be severe.
Well said. Relying on anecdotal success stories and social media hype rather than rigorous clinical trials is a dangerous path that should be firmly rejected by medical authorities.
Expanding access to untested drugs like ivermectin for cancer treatment is concerning. We need to rely on rigorous scientific evidence, not anecdotal claims or social media hype. Promoting unproven therapies could put patients at risk.
I agree. Responsible policymaking should prioritize patient safety and follow FDA guidance, not cater to misinformation campaigns.
While I understand the desire for alternative treatments, expanding access to ivermectin for cancer is not the answer. The lack of scientific evidence and FDA approval means this could be an unnecessary risk for patients. Policymakers should focus on proven, safe therapies.
Well said. Relying on unproven remedies, no matter how much they’re promoted online, is a dangerous path that should be firmly rejected by medical authorities.
Promoting ivermectin as a cancer therapy without FDA approval is extremely irresponsible. Patients deserve access to treatments that have been rigorously tested and proven safe and effective, not unproven remedies hyped on social media.
Well said. Policymakers should be very cautious about expanding access to ivermectin for unapproved uses, as the risks clearly outweigh any potential benefits.